List of Tables
Table 1: Gastrointestinal Therapeutics Market, Irritable Bowel Syndrome, Classification, 2009
Table 2: Gastrointestinal Therapeutics Market, Treatment Recommendations for Irritable Bowel Syndrome, 2009
Table 3: Gastrointestinal Therapeutics Market, Classification of Ulcerative Colitis, 2004
Table 4: Gastrointestinal Therapeutics Market, Diagnosis of Ulcerative Colitis, 2007
Table 5: Gastrointestinal Therapeutics Market, Difference Between Ulcerative Colitis and Crohn’s Disease, 2007
Table 6: Gastrointestinal Therapeutics Market, Treatment Options of Ulcerative Colitis, 2011
Table 7: Gastrointestinal Therapeutics Market, Classification of Crohn’s Disease, 2013
Table 8: Gastrointestinal Therapeutics Market, Percentage of Patients Affected by Symptoms of Crohn’s Disease (%), 2012
Table 9: Gastrointestinal Therapeutics Market, Treatment Options for Crohn’s Disease, 2009
Table 10: Gastrointestinal Therapeutics Market, Global, Pipeline (Discovery), 2013
Table 11: Gastrointestinal Therapeutics Market, Global, Pipeline (Preclinical), 2013
Table 12: Gastrointestinal Therapeutics Market, Global, Pipeline (IND/CTA-filed), 2013
Table 13: Gastrointestinal Therapeutics Market, Global, Pipeline (Phase I), 2013
Table 14: Gastrointestinal Therapeutics Market, Global, Pipeline (Phase II), 2013
Table 15: Gastrointestinal Therapeutics Market, Global, Pipeline (Phase III), 2013
Table 16: Gastrointestinal Therapeutics Market, Global, Pipeline (Pre-Registration), 2013
Table 17: Gastrointestinal Therapeutics Market, Global, Pipeline (Undisclosed), 2012
Table 18: Gastrointestinal Therapeutics Asia-Pacific Markets, Irritable Bowel Syndrome, Market Forecast, 2012–2019
Table 19: Gastrointestinal Therapeutics Market, Asia-Pacific Markets, Ulcerative Colitis, Market Forecast, 2012–2019
Table 20: Gastrointestinal Therapeutics Market, Asia-Pacific Markets, Crohn’s Disease, Market Forecast, 2012–2019
Table 21: Gastrointestinal Therapeutics Market, Australia, Irritable Bowel Syndrome, Market Forecast, 2012–2019
Table 22: Gastrointestinal Therapeutics Market, Australia, Ulcerative Colitis, Market Forecast, 2012–2019
Table 23: Gastrointestinal Therapeutics Market, Australia, Crohn’s Disease, Market Forecast, 2012–2019
Table 24: Gastrointestinal Therapeutics Market, India, Irritable Bowel Syndrome, Market Forecast, 2012–2019
Table 25: Gastrointestinal Therapeutics Market, India, Ulcerative Colitis, Market Forecast, 2012–2019
Table 26: Gastrointestinal Therapeutics Market, India, Crohn’s Disease, Market Forecast, 2012–2019
Table 27: Gastrointestinal Therapeutics Market, China, Irritable Bowel Syndrome, Market Forecast, 2012–2019
Table 28: Gastrointestinal Therapeutics Market, China, Ulcerative Colitis, Market Forecast, 2012–2019
Table 29: Gastrointestinal Therapeutics Market, China, Crohn’s Disease, Market Forecast, 2012–2019
Table 30: Gastrointestinal Therapeutics Market, Japan, Irritable Bowel Syndrome, Market Forecast, 2012–2019
Table 31: Gastrointestinal Therapeutics Market, Japan, Ulcerative Colitis, Market Forecast, 2012–2019
Table 32: Gastrointestinal Therapeutics Market, Japan, Crohn’s Disease, Market Forecast, 2012–2019